Paraneoplastic Neurological Syndromes

Paraneoplastic Neurological Syndromes---34

When Cancer Triggers the Nervous System

Paraneoplastic Neurological Syndromes (PNS) are rare, complex conditions that occur when the body’s immune system, while fighting cancer, mistakenly attacks parts of the nervous system. These syndromes are not caused directly by the tumor itself or its spread, but by the immune response associated with the cancer. At Rochana Medical Center, we offer expert evaluation and management of PNS under the care of Dr. Umesh T, a Senior Consultant Neurologist with over 31 years of clinical experience in advanced neuroimmunology.

Understanding Paraneoplastic Syndromes

PNS can affect any part of the nervous system — the brain, spinal cord, peripheral nerves, or muscles — and may develop before the cancer is even diagnosed. They are most commonly associated with cancers such as:

  • Lung cancer (especially small cell lung cancer)

  • Breast cancer

  • Ovarian and uterine cancers

  • Lymphomas and thymomas

Common Paraneoplastic Neurological Syndromes
  • Paraneoplastic limbic encephalitis – memory loss, confusion, mood changes

  • Cerebellar degeneration – imbalance, tremors, difficulty speaking

  • Sensory neuropathy – numbness, tingling, or pain in limbs

  • Myelopathy – spinal cord dysfunction causing weakness or paralysis

  • Neuromuscular junction disorders – such as Lambert-Eaton Myasthenic Syndrome

Symptoms to Watch For
  • Rapid memory loss or personality changes

  • Difficulty walking or maintaining balance

  • Muscle weakness or unusual fatigue

  • Seizures or hallucinations

  • Unexplained sensory disturbances

Early diagnosis is essential, as neurological symptoms may appear months before the cancer is detected.

Our Approach to Diagnosis and Treatment

At Rochana Medical Center, we use a multidisciplinary, evidence-based approach:

  • Detailed neurological evaluation and symptom tracking

  • Antibody testing (anti-Hu, anti-Yo, anti-Ri, etc.)

  • Cancer screening and imaging to identify underlying tumors

  • Immunotherapy including steroids, IVIG, and plasmapheresis

  • Targeted cancer treatment in collaboration with oncologists

  • Supportive care and neuro-rehabilitation